Stocks and Investing
Stocks and Investing
Wed, April 10, 2024
[ Wed, Apr 10th 2024
] - WOPRAI
[ Wed, Apr 10th 2024
] - WOPRAI
[ Wed, Apr 10th 2024
] - WOPRAI
[ Wed, Apr 10th 2024
] - WOPRAI
[ Wed, Apr 10th 2024
] - WOPRAI
[ Wed, Apr 10th 2024
] - WOPRAI
[ Wed, Apr 10th 2024
] - WOPRAI
[ Wed, Apr 10th 2024
] - WOPRAI
[ Wed, Apr 10th 2024
] - WOPRAI
[ Wed, Apr 10th 2024
] - WOPRAI
[ Wed, Apr 10th 2024
] - WOPRAI
[ Wed, Apr 10th 2024
] - WOPRAI
[ Wed, Apr 10th 2024
] - WOPRAI
[ Wed, Apr 10th 2024
] - WOPRAI
[ Wed, Apr 10th 2024
] - WOPRAI
[ Wed, Apr 10th 2024
] - WOPRAI
[ Wed, Apr 10th 2024
] - WOPRAI
[ Wed, Apr 10th 2024
] - WOPRAI
[ Wed, Apr 10th 2024
] - WOPRAI
[ Wed, Apr 10th 2024
] - WOPRAI
[ Wed, Apr 10th 2024
] - WOPRAI
[ Wed, Apr 10th 2024
] - WOPRAI
[ Wed, Apr 10th 2024
] - WOPRAI
[ Wed, Apr 10th 2024
] - WOPRAI
[ Wed, Apr 10th 2024
] - WOPRAI
[ Wed, Apr 10th 2024
] - WOPRAI
[ Wed, Apr 10th 2024
] - WOPRAI
[ Wed, Apr 10th 2024
] - WOPRAI
Serge Belanger Reiterated (BCRX) at Strong Buy and Held Target at $12 on, Apr 10th, 2024
Serge Belanger of Needham, Reiterated "BioCryst Pharmaceuticals, Inc." (BCRX) at Strong Buy and Held Target at $12 on, Apr 10th, 2024.
Serge, nor any peers, have made any analyst calls on BCRX in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources